Showing 1 - 13 results of 13 for search 'Manuel Galan-Gutierrez', query time: 0.04s
Refine Results
-
1
Lichenoid drug eruption due to eprosartan/hydrochlorothiacide by Ricardo Ruiz-Villaverde, Manuel Galan-Gutierrez
Published 2011-09-01
Article -
2
Zosteriform morphea: Wolf’s isotopic response in an immunocompetent patient by Ricardo Ruiz-Villaverde, Daniel Sánchez-Cano, Manuel Galán-Gutiérrez
Published 2011-10-01
Article -
3
-
4
-
5
Risankizumab: Efficacy, Safety, and Survival in the Mid-Term (52 Weeks) in Real Clinical Practice in Andalusia, Spain, According to the Therapeutic Goals of the Spanish Psoriatic G... by Ricardo Ruiz-Villaverde, Lourdes Rodriguez-Fernandez-Freire, Amalia Pérez-Gil, Pilar Font-Ugalde, Manuel Galán-Gutiérrez
Published 2022-11-01
Article -
6
Super-Responders in Moderate–Severe Psoriasis under Guselkumab Treatment: Myths, Realities and Future Perspectives by Ricardo Ruiz-Villaverde, Fiorella Vasquez-Chinchay, Lourdes Rodriguez-Fernandez-Freire, Jose C. Armario-Hita, Amalia Pérez-Gil, Manuel Galán-Gutiérrez
Published 2022-09-01
Article -
7
Effectiveness, survival and safety of guselkumab attending to basal characteristics in moderate-to-severe psoriatic patients: a cohort study [version 2; peer review: 2 approved] by Fiorella Vasquez Chinchay, Manuel Galán-Gutiérrez, Jose C. Armario-Hita, Amalia Pérez-Gil, Ricardo Ruiz-Villaverde, Lourdes Rodriguez-Fernandez-Freire
Published 2022-11-01
Article -
8
-
9
Bimekizumab: Short-Term Effectiveness and Safety in Real Clinical Practice in Andalucia, Spain by Ricardo Ruiz-Villaverde, Lourdes Rodriguez-Fernandez-Freire, Marta Cebolla-Verdugo, Alvaro Prados-Carmona, Carlos Hernández-Montoya, José Carlos Armario-Hita, Manuel Galán-Gutiérrez
Published 2024-02-01
Article -
10
Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis by José-Juan Pereyra-Rodriguez, Sara Alcantara-Luna, Javier Domínguez-Cruz, Manuel Galán-Gutiérrez, Ricardo Ruiz-Villaverde, Samuel Vilar-Palomo, Jose-Carlos Armario-Hita
Published 2021-09-01
Article -
11
Optimising the Therapeutic Interval for Biologics in Patients with Psoriasis by Jose Manuel Dodero-Anillo, Inmaculada Concepcion Lozano-Cuadra, Esmeralda Rios-Sanchez, Maria Jose Pedrosa-Martinez, Jose Carlos Ruiz-Carrascosa, Manuel Galan-Gutierrez, Jose Carlos Armario-Hita
Published 2022-12-01
Article -
12
Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review by Angela Ayen-Rodríguez, José-Juan Pereyra-Rodríguez, Francisco J. Navarro-Triviño, Sara Alcantara-Luna, Javier Domínguez-Cruz, Manuel Galán-Gutiérrez, Samuel Vilar-Palomo, Jose Carlos Armario-Hita, Ricardo Ruiz-Villaverde
Published 2022-07-01
Article -
13
Multicenter Retrospective Andalusian Study of the Use of Sonidegib for the Treatment of Local Advanced Basal Cell Carcinoma in Real Clinical Practice by Ricardo Ruiz-Villaverde, Enrique Herrera-Acosta, Andres Ruiz de Casas, Isabel M. Villegas-Romero, Fátima G. Moreno-Suárez, Francisco Vílchez-Márquez, Manuel Galán-Gutiérrez, Maria Carmen Vázquez-Bayo, Sandra Cases-Mérida, Francisco M. Almazán-Fernández
Published 2023-08-01
Article